Literature DB >> 709452

Probable interaction of loperamide and cholestyramine.

T Y Ti, H G Giles, E M Sellers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 709452      PMCID: PMC1818457     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  The influence of cholestyramine on thyroxine absorption.

Authors:  R C Northcutt; J N Stiel; J W Hollifield; E G Stant
Journal:  JAMA       Date:  1969-06-09       Impact factor: 56.272

2.  Interaction of warfarin and nonsystemic gastrointestinal drugs.

Authors:  D S Robinson; D M Benjamin; J J McCormack
Journal:  Clin Pharmacol Ther       Date:  1971 May-Jun       Impact factor: 6.875

3.  Loperamide: a new antidiarrheal agent in the treatment of chronic diarrhea.

Authors:  J T Galambos; T Hersh; S Schroder; J Wenger
Journal:  Gastroenterology       Date:  1976-06       Impact factor: 22.682

4.  Interruption of the enterohepatic circulation of digitoxin by cholestyramine. II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man.

Authors:  J H Caldwell; C A Bush; N J Greenberger
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

  4 in total
  2 in total

Review 1.  A comparative review of the adverse effects of treatments for hyperlipidaemia.

Authors:  A Steiner; B Weisser; W Vetter
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

Review 2.  Adverse effects of hypolipidaemic drugs.

Authors:  L C Knodel; R L Talbert
Journal:  Med Toxicol       Date:  1987 Jan-Feb
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.